CME/CE from MPR


MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for myCME.com. See below for a list of each quarter's courses. Click here to visit MPR's website.




Latest Courses


MPR Drug News


Verdict Announced for Pharmacist at Center of NECC Meningitis Outbreak

The fungal meningitis outbreak was caused by contaminated injections of preservative-free methylprednisolone acetate (MPA), which sickened over 700 people and killed 64.

Researchers Hope to Curb Alcoholism Using Two OTC Supplements

The study will investigate how these two supplements may improve brain function and mood control in patients diagnosed bi-polar.

Chronic Dry Eye Med Available in Preservative-Free, Multidose Form

Restasis, a calcineurin inhibitor immunosuppressant, helps increase the eyes' natural ability to produce tears in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.

FDA Fast Tracks Recombinant ADAMTS13 Enzyme Replacement Therapy

Shire announced that the FDA has granted Fast Track designation to SHP655 (historically BAX930) for the treatment of acute episodes of hereditary thrombotic thrombocytopenic purpura (hTTP) in patients with a constitutional ADAMTS13 deficiency.

Orphan Drug Status Granted for C3 Glomerulopathy Treatment

Patients with C3G experience progressive deterioration in renal function, ultimately leading to renal failure requiring dialysis and kidney transplant, if left untreated.